Finance

Beta
Lists
300204:SHE
Staidson (Beijing) BioPharmcutcls Co Ltd
CNÂ¥20.56
-0.87%
(-0.18) 1D
Jun 16, 3:04:31 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300204...
Open
CNÂ¥20.78
High
CNÂ¥21.18
Low
CNÂ¥20.42
Mkt. cap
9.91B
Avg. vol.
24.94M
Volume
15.83M
52-wk high
CNÂ¥66.66
52-wk low
CNÂ¥19.82
EPS
-CNÂ¥0.18
Shares outstanding
477.77M
No. of employees
491
Open
CNÂ¥20.78
High
CNÂ¥21.18
Low
CNÂ¥20.42
Mkt. cap
9.91B
Avg. vol.
24.94M
Volume
15.83M
52-wk high
CNÂ¥66.66
52-wk low
CNÂ¥19.82
EPS
-CNÂ¥0.18
Shares outstanding
477.77M
No. of employees
491
News stories
From sources across the web
About Staidson (Beijing) BioPharmcutcls Co Ltd
CEO-
Employees491
FoundedAug 16, 2002
Headquarters-
SectorBiotechnology
Websitestaidson.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
62.38M
54.94M
39.69M
46.90M
Cost of goods sold
13.98M
11.23M
11.32M
10.23M
Cost of revenue
13.98M
11.23M
11.32M
10.23M
Research and development expenses
29.93M
11.77M
26.83M
12.21M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
44.25M
35.82M
47.90M
29.37M
Operating expense
74.92M
49.02M
74.75M
42.24M
Total operating expenses
88.89M
60.25M
86.07M
52.47M
Operating income
-26.51M
-5.31M
-46.38M
-5.57M
Other non operating income
-52.15K
11.61K
-92.37K
-220.74K
EBT including unusual items
-24.75M
-8.64M
-50.52M
-9.28M
EBT excluding unusual items
-26.57M
-9.39M
-49.70M
-8.89M
Income tax expense
77.96K
1.94K
-296.49K
-1.49K
Effective tax rate
-0.31%
-0.02%
0.59%
0.02%
Other operating expenses
736.68K
1.35M
176.72K
603.57K
Net income
-22.30M
-6.05M
-47.07M
-8.43M
Net profit margin
-35.75%
-11.02%
-118.59%
-17.98%
Earnings per share
-
-
-
-
Interest and investment income
82.71K
347.22K
489.14K
365.59K
Interest expense
-143.56K
-4.44M
-3.45M
-3.66M
Net interest expenses
-60.85K
-4.09M
-2.96M
-3.29M
Depreciation and amortization charges
-
-
-
-
EBITDA
-20.39M
268.67K
-40.49M
317.58K
Gain or loss from assets sale
-1.11M
1.11M
-875.15K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer